Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
J.P. Morgan
Biotech
Biopharma VC activity suggests growth has returned
With VC cash pouring into biopharma, steady M&A deals and a widening IPO market, J.P. Morgan sees the industry returning to growth—finally.
Annalee Armstrong
Jul 29, 2024 10:26am
J.P. Morgan arm secures $500M+ for first biotech-only fund
Jun 14, 2024 10:37am
Mindstate takes trip to clinic with first AI-derived psychedelic
Mar 13, 2024 9:00am
JPM's private capital team ‘actively looking’ at psychedelics
Feb 28, 2024 7:00am
Rubius execs depart as the walls close in—Chutes & Ladders
Nov 4, 2022 9:30am
J.P. Morgan extends new private equity arm toward life sciences
Nov 3, 2022 5:00am
